| AJCC | American Joint Committee on Cancer |
| AP-1 | Activator protein-1 |
| BDNF | Brain-derived neurotrophic factor |
| CI | Confidence interval |
| cN | Clinical nodal |
| CT | Computed tomography |
| DNA | Deoxyribonucleic acid |
| DOI | Depth of invasion |
| EGFR | Epidermal growth factor receptors |
| EMT | Epithelial to mesenchymal transition |
| ENE | Extracapsular nodal extension |
| ERK | Extracellular-regulated protein kinase |
| FDA | Food and Drug Administration |
| FGFR | Fibroblast growth factor receptor |
| GALR | Galanin receptor |
| GDNF | Glial cell-derived neurotrophic factor |
| GFAP | Glial fibrillary acidic protein |
| GFRalpha1 | GDNF family receptor-alpha 1 |
| HPV | Human papilloma virus |
| HR | Hazard ratio |
| IMRT | Intensity-modulated radiation therapy |
| LOH | Loss of heterozygosity |
| M | Metastasis |
| MAPK | Mitogen-activated protein kinase |
| MMP | Matrix metalloproteinase |
| MR | Magnetic resonance |
| mRNA | Messenger ribonucleic acid |
| NCAM | Neural cell adhesion molecule |
| NFATC | Nuclear factor of activated T cells |
| NGF | Nerve growth factor |
| OR | Odds ratio |
| p75NTR | p75 neurotrophin receptors |
| PD-L1 | Programed cell death -ligand 1 |
| pN | Pathological nodal |
| PNI | Perineural invasion |
| RET | REarranged during Transfection |
| SCC | Squamous cell carcinoma |
| shRNA | Short hairpin ribonucleic acid |
| T | Tumor |
| TNF | Tumor necrosis factor |
| TrkA | Tropomyosin receptor kinase A |
| TrkB | Tropomyosin receptor kinase B |